New benzimidazole derivatives: selective and orally active 5-HT 3 receptor antagonists

Author： Pascual D.   Giron R.   Alsasua A.   Benhamu B.   Lopez-Rodrguez M.L.   Martn M.I.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.462, Iss.1, 2003-02, pp. : 99-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-HT3 receptor antagonists

By Higgins G.A.   Kilpatrick G.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2183-2188

Informa Healthcare

Access to resources Recommend Favorite

Advances in use of the 5-HT3 receptor antagonists

By Walton S.M.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 207-223

Informa Healthcare

Access to resources Recommend Favorite

Are All 5-HT3 Receptor Antagonists the Same?

By McNulty Robert  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 1, 2007-01 ,pp. : 35-43

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Selective Serotonin 5-HT3 Receptor Antagonists for Postoperative Nausea and Vomiting: Are They All the Same?

By Tong J. Gan  

CNS Drugs, Vol. 19, Iss. 3, 2005-01 ,pp. : 225-238

Adis International

Access to resources Recommend Favorite

Cataleptogenic effect of subtype selective 5-HT receptor antagonists in the rat

By Kalkman H.O.   Neumann V.   Nozulak J.   Tricklebank M.D.  

European Journal of Pharmacology, Vol. 343, Iss. 2, 1998-02 ,pp. : 201-207

Elsevier

Access to resources Recommend Favorite